Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon
- PMID: 33749558
- DOI: 10.2174/1389201022666210322124348
Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon
Abstract
The world population has suffered as a result of the COVID-19 pandemic. The disease has become life-threatening in a very short time, harming citizens and the economic systems globally. The novel virus SARS-CoV-2 has been known as the causative agent of COVID-19. The SARS-CoV-2 is a single-stranded RNA virus having ~30 kb genomic components, which are 70% identical to SARS-CoV. The main process of the pathophysiology of COVID-19 has been associated with the interaction of a novel coronavirus with host cell receptor, angiotensin-converting enzyme-2 (ACE 2), by fusion. Therapeutic agents having serine protease inhibitors and ACE-2 blockers may be explored for the treatment by inhibiting the viral target such as Mpro, RdRp, PLpro, and helicase. Herbal medicine has a wide array of chemical entities with potential health benefits, including antiviral activity, which may be explored as an alternative treatment for COVID-19. The herbal bioactives like catechins, andrographolide, hesperidin, biorobin, scutellarein, silvestrol, shikonin, tryptanthrin, vitexin quercetin, myricetin, caffeic acid, psoralidin, luteolin, etc. have shown potential inhibitory effect against SARS-CoV-2. Recent research reports indicate that the various plant secondary metabolites have shown potential antiviral activities. The present review article highlights the recent information on the mechanism of actions and applications of herbal medicine in the treatment of COVID-19.
Keywords: COVID-19; SARS-CoV-2; catechin.; coronavirus; herbal bioactive; herbal medicine.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
-
Effective inhibition of coronavirus replication by Polygonum cuspidatum.Front Biosci (Landmark Ed). 2021 Oct 30;26(10):789-798. doi: 10.52586/4988. Front Biosci (Landmark Ed). 2021. PMID: 34719206
-
Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.Phys Chem Chem Phys. 2020 Nov 21;22(43):25335-25343. doi: 10.1039/d0cp03867a. Epub 2020 Nov 3. Phys Chem Chem Phys. 2020. PMID: 33140777
-
Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.Curr Pharm Des. 2021 Oct 5;27(31):3389-3398. doi: 10.2174/1381612827666210705163807. Curr Pharm Des. 2021. PMID: 34225610
-
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.Curr Pharm Des. 2021;27(33):3526-3550. doi: 10.2174/1381612826666201118111151. Curr Pharm Des. 2021. PMID: 33213322 Review.
Cited by
-
Application of metabolomics in quality control of traditional Chinese medicines: a review.Front Plant Sci. 2024 Nov 15;15:1463666. doi: 10.3389/fpls.2024.1463666. eCollection 2024. Front Plant Sci. 2024. PMID: 39619843 Free PMC article. Review.
-
In Silico and In Vitro Studies of Alchemilla viridiflora Rothm-Polyphenols' Potential for Inhibition of SARS-CoV-2 Internalization.Molecules. 2022 Aug 14;27(16):5174. doi: 10.3390/molecules27165174. Molecules. 2022. PMID: 36014415 Free PMC article.
-
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach.Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z. Sci Rep. 2025. PMID: 40596019 Free PMC article.
-
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis.Curr Pharm Des. 2024;30(6):420-439. doi: 10.2174/0113816128295753240129074035. Curr Pharm Des. 2024. PMID: 38299405 Review.
-
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.Curr Genomics. 2024 Apr 8;25(2):69-87. doi: 10.2174/0113892029291098240129113500. Curr Genomics. 2024. PMID: 38751601 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous